Pharmaceutical Technology Europe-03-02-2017

Click the title above to open the Pharmaceutical Technology Europe 2017 Outsourcing Supplement in an interactive PDF format.

The article reviews strategies for firms with or without existing in-house capacities and the pros and cons for outsourcing bio/pharmaceutical development and manufacturing.

This article reviews experiences with the outcome of in-house audits, audits by third parties, and purchased audit reports.

Having an effective and granular data management process in place will enable companies to meet the requirements of IDMP as well as help usher in a new age of digital-based identification, in which organizations can easily share data across borders.